Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00180453
Show Display Options
Rank Status Study
1 Completed SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System
Conditions: Coronary Artery Disease;   Everolimus;   Vascular Disease;   Myocardial Ischemia;   Coronary Artery Stenosis
Interventions: Device: Coronary artery drug eluting stent placement;   Device: Coronary artery stent placement

Study has passed its completion date and status has not been verified in more than two years.